HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells

被引:0
|
作者
M-L Gougeon
M-T Melki
H Saïdi
机构
[1] Antiviral Immunity,Infection and Epidemiology Department
[2] Biotherapy and Vaccine Unit,undefined
[3] Institut Pasteur,undefined
来源
Cell Death & Differentiation | 2012年 / 19卷
关键词
dendritic cell; HIV; HMGB1; natural killer cell; TRAIL;
D O I
暂无
中图分类号
学科分类号
摘要
Dendritic cells (DCs) initiate immune responses by transporting antigens and migrating to lymphoid tissues to initiate T-cell responses. DCs are located in the mucosal surfaces that are involved in human immunodeficiency virus (HIV) transmission and they are probably among the earliest targets of HIV-1 infection. DCs have an important role in viral transmission and dissemination, and HIV-1 has evolved different strategies to evade DC antiviral activity. High mobility group box 1 (HMGB1) is a DNA-binding nuclear protein that can act as an alarmin, a danger signal to alert the innate immune system for the initiation of host defense. It is the prototypic damage-associated molecular pattern molecule, and it can be secreted by innate cells, including DCs and natural killer (NK) cells. The fate of DCs is dependent on a cognate interaction with NK cells, which involves HMGB1 expressed at NK–DC synapse. HMGB1 is essential for DC maturation, migration to lymphoid tissues and functional type-1 polarization of naïve T cells. This review highlights the latest advances in our understanding of the impact of HIV on the interactions between HMGB1 and DCs, focusing on the mechanisms of HMGB1-dependent viral dissemination and persistence in DCs, and discussing the consequences on antiviral innate immunity, immune activation and HIV pathogenesis.
引用
收藏
页码:96 / 106
页数:10
相关论文
共 50 条
  • [21] INFECTION OF DENDRITIC CELLS WITH HIV-1 - VIRUS LOAD REGULATES STIMULATION AND SUPPRESSION OF T-CELL ACTIVITY
    KNIGHT, SC
    MACATONIA, SE
    PATTERSON, S
    RESEARCH IN VIROLOGY, 1993, 144 (01): : 75 - 80
  • [22] Fucosylated lactosamines participate in adhesion of HIV-1 envelope glycoprotein to dendritic cells
    B. Monzavi-Karbassi
    P. Luo
    G. Cunto-Amesty
    F. Jousheghany
    A. Pashov
    D. Weissman
    T. Kieber-Emmons
    Archives of Virology, 2003, 149 : 75 - 91
  • [23] Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1
    Garcia, Felipe
    Routy, Jean-Pierre
    VACCINE, 2011, 29 (38) : 6454 - 6463
  • [24] Recombinant HMGB1 A box protein inhibits Th17 responses in mice with neutrophilic asthma by suppressing dendritic cell-mediated Th17 polarization
    Zhang, Fang
    Huang, Gang
    Hu, Bo
    Qian, Gui-sheng
    Song, Yong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 24 (01) : 110 - 118
  • [25] Dendritic cells from HIV-1-infected patients naturally express HIV-1 gp120 V3 loop-derived peptide ligands
    Fernandez, MH
    Pitman, RJ
    Hawrylowicz, CM
    Rees, ADM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (10) : 3144 - 3153
  • [26] The functional consequences of delivery of HIV-1 Nef to dendritic cells using an adenoviral vector
    Maccormac, LP
    Jacque, JM
    Chain, B
    VACCINE, 2004, 22 (3-4) : 528 - 535
  • [27] HIV-1 selection by epidermal dendritic cells during transmission across human skin
    Reece, JC
    Handley, AJ
    Anstee, EJ
    Morrison, WA
    Crowe, SM
    Cameron, PU
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10): : 1623 - 1631
  • [28] Unique stimulatory properties of myeloid dendritic cells in individuals with "elite" HIV-1 control
    Huang, J.
    Poole, L.
    Burke, P.
    Cung, T.
    Trocha, A.
    Pereyra, F.
    Borges, L.
    Lichterfeld, M.
    Yu, X.
    RETROVIROLOGY, 2009, 6
  • [29] LAPTM5 Restricts HIV-1 Infection in Dendritic Cells and Is Counteracted by Vpr
    Ouyang, Jiayue
    Xiong, Ying
    Shang, Hong
    Liang, Guoxin
    MICROBIOLOGY SPECTRUM, 2022, 10 (02):
  • [30] The role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest
    Sharifi, Hamayun J.
    Furuya, Andrea M.
    de Noronha, Carlos M. C.
    CURRENT OPINION IN HIV AND AIDS, 2012, 7 (02) : 187 - 194